|1.||Nanda, Kavita: 2 articles (12/2015 - 01/2012)|
|2.||Halpern, Vera: 2 articles (12/2015 - 01/2012)|
|3.||Gallo, Maria F: 2 articles (01/2012 - 01/2008)|
|4.||Grimes, David A: 2 articles (01/2012 - 01/2008)|
|5.||Lopez, Laureen M: 2 articles (01/2012 - 01/2008)|
|6.||Schulz, Kenneth F: 2 articles (01/2012 - 01/2008)|
|7.||Gallo, M F: 2 articles (01/2007 - 01/2005)|
|8.||Grimes, D A: 2 articles (01/2007 - 01/2005)|
|9.||Lopez, L M: 2 articles (01/2007 - 01/2005)|
|10.||Schulz, K F: 2 articles (01/2007 - 01/2005)|
01/01/2012 - "6) Norethisterone enanthate 200 mg with TU 1000 mg led to more azoospermia when given every 8 weeks versus 12 weeks. "
10/01/1997 - "Monthly intramuscular injection with an Alzet minipump of depot norethisterone enanthate and estradiol valerate (E-val) produced azoospermia in 13 adult male bonnet monkeys within 60-150 days. "
04/01/1981 - "Bilateral insertion of silastic capsules releasing 38-44 micrograms norethisterone enanthate/24 h into the epididymal fat-pads was found to induce complete azoospermia leading to infertility in adult male rabbits 8 weeks after insertion of the progestin implants. "
01/01/2007 - "A few important differences emerged from these trials: levonorgestrel implants combined with injectable testosterone enanthate (TE) were more effective than levonorgestrel 125 microg daily combined with testosterone patches; levonorgestrel 500 mug daily improved the effectiveness of TE 100 mg injected weekly; desogestrel 150 mug was less effective than desogestrel 300 mug (with testosterone pellets); testosterone undecanoate (TU) 500 mg was less likely to produce azoospermia than TU 1000 mg (with levonorgestrel implants); norethisterone enanthate 200 mg with TU 1000 mg led to more azoospermia when given every 8 weeks versus 12 weeks; four implants of 7-alpha-methyl-19-nortestosterone (MENT) were more effective than two MENT implants. "
07/01/1991 - "Endometrial bleeding and alteration in blood coagulation, fibrinolysis, ovarian function and endometrial morphology were studied in twelve normally menstruating women who received the injectable contraceptive norethisterone enanthate (NET-EN) 200mg at 60-day intervals. "
12/01/1991 - "Long-term use of depot-norethisterone enanthate: effect on blood coagulation factors and menstrual bleeding patterns."
07/01/1991 - "Effect of norethisterone enanthate on endometrial bleeding and changes in coagulation function, ovarian hormones and endometrial histology in Thai women."
06/01/1983 - "The most important side effect observed with these 2 agents is a complete disruption of the menstrual bleeding pattern, leading - in some cases - to total amenorrhoea, which is more frequent with depot medroxyprogesterone acetate than with norethisterone enanthate. "
06/01/2006 - "This prospective observational study evaluated the bleeding patterns of adolescents receiving a monthly injectable contraceptive containing norethisterone enanthate 50 mg plus estradiol valerate 5 mg. The study enrolled 73 volunteers aged between 14 and 19 years; of these patients, 38 (52%) recorded their menstrual cycles during 1 year. "
01/01/2008 - "Combination injectable contraceptives include depot medroxyprogesterone acetate (DMPA) 25 mg plus estradiol cypionate (E(2)C) 5 mg, as well as norethisterone enanthate (NET-EN) 50 mg plus estradiol valerate (E(2)V) 5 mg. These contraceptives resulted in lower rates of early study discontinuation due to amenorrhea or other bleeding problems than progestin-only contraceptives. "
01/01/2005 - "Combination injectable contraceptives include depot medroxyprogesterone acetate (DMPA) 25 mg plus estradiol cypionate (E(2)C) 5 mg, as well as norethisterone enanthate (NET-EN) 50 mg plus estradiol valerate (E(2)V) 5 mg. These combination injectable contraceptives resulted in lower rates of early study discontinuation due to amenorrhea or other bleeding problems, but had higher rates of discontinuation due to other reasons than the progestin-only comparison contraceptives. "
|4.||Postpartum Depression (Post-Natal Depression)
01/01/2008 - "Norethisterone enanthate, a synthetic progestogen, administered within 48 hours of delivery was associated with a significantly higher risk of developing postpartum depression. "
01/01/2000 - "Long-acting norethisterone enanthate is associated with an increased risk of postnatal depression. "
01/01/2000 - "Depot norethisterone enanthate given within 48 hours of delivery and lasting 8-12 weeks was associated with significantly higher postpartum depression scores than placebo. "
10/01/1998 - "A double-blind randomised placebo controlled trial of postnatal norethisterone enanthate: the effect on postnatal depression and serum hormones."
10/01/1998 - "Long-acting norethisterone enanthate given within 48 hours of delivery is associated with an increased risk of developing postnatal depression and causes suppression of endogenous ovarian hormone secretion."
|5.||HIV Infections (HIV Infection)
01/01/2015 - "We conducted an individual participant data (IPD) meta-analysis of studies from sub-Saharan Africa to compare the incidence of HIV infection in women using combined oral contraceptives (COCs) or the injectable progestins depot-medroxyprogesterone acetate (DMPA) or norethisterone enanthate (NET-EN) with women not using HC. "
|1.||Levonorgestrel (Plan B)
|5.||testosterone enanthate (Delatestryl)
|6.||Medroxyprogesterone Acetate (Depo-Provera)
|8.||estradiol valerate (Delestrogen)
|9.||Contraceptive Agents (Contraceptives)
|10.||estradiol 17 beta-cypionate (Depo-estradiol)
|3.||Contraception (Birth Control)